falseQ1April 3000017159250001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-05-012026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2026-07-310001715925hyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-05-012026-07-310001715925hyft:AllOtherCountriesMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-04-300001715925hyft:FindersWarrantsMember2026-05-012026-07-310001715925country:US2026-05-012026-07-310001715925hyft:OptionTwoMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925hyft:OptionSixMember2026-07-310001715925hyft:IdeaFamilyBVMember2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2025-07-310001715925hyft:ProjectRevenueMember2025-05-012025-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-04-300001715925hyft:OptionThirteenMember2026-07-310001715925hyft:DeferredAcquisitionPaymentsMember2025-05-012025-07-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2025-05-012026-04-300001715925ifrs-full:LeaseLiabilitiesMember2025-04-300001715925ifrs-full:RestrictedShareUnitsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:OptionThreeMember2026-07-310001715925ifrs-full:DiscontinuedOperationsMember2026-05-012026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-04-300001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2026-07-310001715925hyft:BioClueBVMember2025-05-012026-04-300001715925hyft:OptionEightMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925country:AU2025-05-012025-07-310001715925ifrs-full:IssuedCapitalMember2026-04-300001715925hyft:OptionFourAndFiveMember2026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-04-300001715925country:NL2026-05-012026-07-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-07-310001715925hyft:DeferredAcquisitionPaymentsMember2025-07-310001715925ifrs-full:AdditionalPaidinCapitalMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-05-012026-07-310001715925hyft:TalemTherapeuticsLLCTalemMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-05-012026-07-310001715925ifrs-full:IssuedCapitalMember2025-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:ProductSalesMember2026-05-012026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:LaterThanFiveYearsMember2026-07-310001715925hyft:ImmunoPreciseNetherlandsBVMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-05-012025-07-310001715925hyft:OptionTenMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:LabAndOfficeFacilitiesMember2026-07-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-05-012026-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-05-012026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925hyft:FindersWarrantsMember2026-04-300001715925hyft:ProductSalesMember2025-05-012025-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-04-300001715925ifrs-full:PotentialOrdinaryShareTransactionsMemberifrs-full:TopOfRangeMemberhyft:AtTheMarketEquityOfferingFacilityMember2025-11-072025-11-070001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-04-300001715925hyft:TalemTherapeuticsLLCTalemMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-05-012026-04-300001715925hyft:OptionTwelveMember2026-07-310001715925hyft:OptionOneMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-05-012026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:OptionSixMember2026-05-012026-07-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-05-012026-07-310001715925hyft:FindersWarrantsMember2024-05-012025-04-300001715925hyft:DeferredAcquisitionPaymentsMember2025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-07-310001715925country:BE2026-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:ImmunoPreciseAntibodiesMALLCMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925country:BE2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925hyft:BioStrandBVDBAMindWalkMember2025-05-012026-04-300001715925ifrs-full:DiscontinuedOperationsMember2025-05-012025-07-310001715925hyft:LabAndOfficeFacilitiesMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-04-300001715925hyft:FindersWarrantsMember2025-05-012026-04-300001715925hyft:OptionSevenMember2026-07-310001715925ifrs-full:BottomOfRangeMemberhyft:LabEquipmentMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925hyft:OptionEightMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2026-04-300001715925hyft:LabAndOfficeFacilitiesMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925srt:EuropeMember2025-05-012025-07-310001715925hyft:FindersWarrantsMember2026-07-310001715925ifrs-full:RetainedEarningsMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925country:CA2025-05-012025-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-05-012026-04-300001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2025-05-012026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-05-012025-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-05-012025-07-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:OptionOneMember2026-05-012026-07-310001715925hyft:OptionElevenMember2026-07-310001715925srt:EuropeMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-05-012026-07-310001715925ifrs-full:VehiclesMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925ifrs-full:VehiclesMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:TopOfRangeMemberhyft:LabEquipmentMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2026-05-012026-07-310001715925hyft:OptionTenMember2026-07-3100017159252026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-07-310001715925ifrs-full:RetainedEarningsMember2025-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-04-3000017159252026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925country:BE2025-05-012025-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-05-012026-07-310001715925ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-04-300001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2026-04-300001715925hyft:OptionNineMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-04-300001715925hyft:NetBookValueMember2026-04-300001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-07-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-04-300001715925country:NL2026-07-310001715925hyft:LabEquipmentMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2026-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-07-310001715925hyft:ImmunoPreciseNetherlandsBVMember2025-05-012026-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:NetBookValueMemberhyft:AutomobileMember2026-07-310001715925hyft:OptionSevenMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925ifrs-full:IssuedCapitalMember2025-05-012025-07-310001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2026-05-012026-07-3100017159252025-05-012026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-04-300001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:BioKeyBVMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-04-300001715925hyft:NetBookValueMemberhyft:CertificationsMember2026-07-310001715925hyft:IdeaFamilyBVMember2025-05-012026-04-300001715925hyft:ImmunoPreciseAntibodiesCanadaLtdDBaMindWalkBiologicsMember2026-05-012026-07-310001715925hyft:ImmunoPreciseAntibodiesMALLCMember2026-05-012026-07-310001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-04-300001715925hyft:NetBookValueMemberhyft:CertificationsMember2026-04-3000017159252022-05-310001715925ifrs-full:RestrictedShareUnitsMember2025-05-012026-04-300001715925hyft:OptionThirteenMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:BioClueBVMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:AccumulatedAmortizationMember2026-07-310001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2026-07-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-04-300001715925hyft:CryoStorageMember2025-05-012025-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-04-300001715925country:CA2026-05-012026-07-310001715925ifrs-full:RestrictedShareUnitsMember2025-05-012025-07-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2026-05-012026-07-310001715925country:BE2026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-04-300001715925country:NL2026-04-300001715925ifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:AllOtherCountriesMember2025-05-012025-07-310001715925hyft:MindWalkBVMember2026-07-310001715925hyft:OptionFiveMember2026-07-310001715925ifrs-full:RetainedEarningsMember2025-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-05-012026-07-310001715925ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-07-3100017159252025-04-300001715925hyft:OptionFiveMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-04-300001715925hyft:BioStrandBVDBAMindWalkMember2026-05-012026-07-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2025-05-012026-04-3000017159252026-04-300001715925ifrs-full:LeaseLiabilitiesMember2025-05-012025-07-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-05-012026-07-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMember2026-07-310001715925country:AU2026-05-012026-07-310001715925ifrs-full:RetainedEarningsMember2025-05-012025-07-310001715925srt:NorthAmericaMember2025-05-012025-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:OptionTwoMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-3100017159252025-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:FindersWarrantsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-05-012026-04-3000017159252025-05-012025-07-310001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2026-04-300001715925ifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:ImmunoPreciseAntibodiesCanadaLtdDBaMindWalkBiologicsMember2025-05-012026-04-300001715925ifrs-full:NotLaterThanOneYearMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-04-300001715925country:US2025-05-012025-07-310001715925hyft:ProjectRevenueMember2026-05-012026-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:RetainedEarningsMember2026-07-3100017159252024-05-012025-04-300001715925hyft:AccumulatedAmortizationMember2026-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2026-07-310001715925hyft:BioKeyBVMember2025-05-012026-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-07-310001715925hyft:CryoStorageMember2026-05-012026-07-310001715925hyft:OptionNineMember2026-07-310001715925ifrs-full:BottomOfRangeMemberifrs-full:VehiclesMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:AutomobileMember2026-04-300001715925hyft:OptionThreeMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-05-012026-04-300001715925ifrs-full:RetainedEarningsMember2026-04-300001715925hyft:OptionElevenMember2026-05-012026-07-310001715925country:NL2025-05-012025-07-310001715925hyft:OptionTwelveMember2026-05-012026-07-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-07-310001715925hyft:OptionSevenToTwelveMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-05-012026-04-30iso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:CADiso4217:CADxbrli:sharesiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September, 2026.

 

Commission File Number: 001-39530

 

 

MindWalk Holdings Corp.

Industrious 823 Congress Ave Suite 300 Austin, Texas 78701, United States

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒

Form 40-F ☐

 

 


 

INCORPORATION BY REFERENCE

 

Exhibits 99.1 and 99.2 of this Form 6-K are incorporated by reference into the Registration Statements on Form S-8 (File Nos. 333-256730 and 333-290949) and Registration Statements on Form F-3 (File Nos. 333-281312 and 333-297424) of the Registrant, MindWalk Holdings Corp.

 

EXHIBIT INDEX

 

 

Exhibit

Description

99.1

Management’s Discussion and Analysis for the three months ended July 31, 2026 and 2025

99.2

Condensed Interim Consolidated Financial Statements for the three months ended July 31, 2026 and 2025

99.3

CEO Certification (pursuant to Canadian regulations)

99.4

CFO Certification (pursuant to Canadian regulations)

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

MINDWALK HOLDINGS CORP.

Date: September 14, 2026

 

 

 

 

 

By:

/s/ Jennifer Bath

 

Name:

Jennifer Bath

 

Title:

Chief Executive Officer